TABLE 2.
Comparison of characteristics between normal, obese, and smoking groups.
| Normal |
Obese |
Smoking |
|
| (n = 81) | (n = 59) | (n = 80) | |
| Age (years) | 36 (32–42)a, b | 43 (36–49)a | 44 (34.5–51.5)b |
| BMI (Kg/m2) | 22 (20.1–23.2)a, b | 31.3 (30.4–33)a, c | 23.2 (20.9–24.65)b, c |
| sBP (mmHg) | 115.12 ± 12.04a, b | 131.61 ± 11.37a, c | 121.09 ± 14.03b, c |
| dBP (mmHg) | 70.41 ± 7.85a, b | 86.42 ± 10.44a, c | 77.5 ± 10.53b, c |
| AST (IU/L) | 18 (16–20)a, b | 28 (23–37)a, c | 20.5 (18–25)b, c |
| ALT (IU/L) | 17 (13–22)a, b | 41 (30–70)a, c | 19.5 (16–29)b, c |
| γGTP (IU/L) | 21 (16–31)a, b | 53 (33–91)a, c | 28.5 (19–64.5)b, c |
| Cr (mg/dL) | 0.88 (0.85–0.95)b | 0.86 (0.81–0.92)c | 0.81 (0.75–0.90)b, c |
| UA (mg/dL) | 5.76 ± 1.11a | 6.70 ± 1.10a, c | 5.91 ± 1.10c |
| TCHO (mg/dL) | 187.81 ± 26.76a, b | 209.59 ± 29.13a | 200.11 ± 32.10b |
| TGL (mg/dL) | 77 (54–112)a, b | 137 (102–177)a, c | 93.5 (69.5–132)b, c |
| HDL (mg/dL) | 56 (49–63)a | 48 (42–53)a, c | 56 (49–68)c |
| LDL (mg/dL) | 113.37 ± 24.46a | 136.42 ± 28.96a, c | 121.88 ± 30.94c |
| Glu (mg/dL) | 84.10 ± 6.06a | 96.37 ± 26.48a, c | 87.75 ± 11.48c |
| HbA1c (%) | 5.05 ± 0.23a | 5.62 ± 0.87a, c | 5.23 ± 0.41c |
| FGF21 (pg/ml) | 126 (76.7–187)a, b | 165 (119–269)a | 159.5 (104–250.5)b |
Data are expressed as the mean ± SD or median (interquartile range). The ANOVA followed by Tukey–Kramer pairwise comparison or the Kruskal–Wallis equality-of-populations rank test followed by Dunn’s pairwise comparison was used to test between-group differences.
ap < 0.05 (normal vs. obese).
bp < 0.05 (normal vs. smoking).
cp < 0.05 (obese vs. smoking).
BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, gamma-glutamyl transpeptidase; Cr, creatinine; UA, uric acid; TCHO, total cholesterol; TGL, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Glu, glucose; HbA1c, hemoglobin A1c; FGF21, fibroblast growth factor 21.